In response to Ward and Irwin’s editorial [1], we would like to describe two randomised, controlled, cross-over trials (RCT’s) using Basic Life Support (BLS) airway providers, defined as inexperienced users (IU’s) with annually trained Guedel/Facemask skills who compared ventilation using either the Tulip GT® (TGT®) or a Guedel/Facemask (G/F) in 60 subjects, first in manikins [2] and then in humans [3] using identical protocols but within the limitations of estimation of end tidal CO2 (etCO2) in manikins.